Belgian Pharmaceuticals & Biotech Most Popular Stocks

argenx

Market Cap: €49.7b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

UCB

Market Cap: €47.3b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Financière de Tubize

Market Cap: €9.6b

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.

Hyloris Pharmaceuticals

Market Cap: €123.5m

Operates as a specialty pharmaceutical company in Belgium, the United States, Europe, the Middle East, Africa, and Asia-Pacific.

Celyad Oncology

Market Cap: €10.4m

A biotechnology company, focuses on unlocking the potential of its intellectual property.

BioSenic

Market Cap: €1.3m

A biotechnology company, develops cell therapy products and treatments for autoimmune and inflammatory diseases in Belgium and France.

Oxurion

Market Cap: €248.3k

A biopharmaceutical company, develops medicines for vascular retinal disorder in Belgium.